Axsome Therapeutics
Price & Volume
Stats
See more52W Range | $96.09-$191.50 |
Market Cap | $9.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $638.4M |
Revenue Growth (YoY) | 65% |
Gross Profit (12 Mos) | $591M |
Diluted EPS | -$3.67 |
News
See moreYahoo Finance • 23 hours ago
Axsome Faces Key Auvelity FDA Call And Insider Sentiment Test
Yahoo Finance • 3 days ago
Axsome Therapeutics Upside Tied to Auvelity FDA Decision, $2 Billion Sales Opportunity Seen, UBS Says
Yahoo Finance • 5 days ago
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
About
CEO | Dr. Herriot Tabuteau M.D. |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 925 |
